male
type
diabet
mellitu
hypertens
hyperlipidemia
present
fever
hypotens
decreas
urin
output
admit
intens
care
unit
sepsi
due
pyelonephr
addit
broadspectrum
antibiot
patient
receiv
one
liter
fl
uid
resuscit
salin
two
hour
present
blood
pressur
current
mmhg
temperatur
puls
rate
beatsminut
respiratori
rate
breathsminut
hematocrit
blood
sugar
mgdl
serum
lactat
mgdl
follow
like
improv
mortal
particular
patient
continu
fl
uid
resuscit
colloid
ad
b
intens
insulin
therapi
maintain
euglycemia
c
vasopressor
therapi
bicarbon
infus
e
transfus
prbc
answer
c
patient
respond
aggress
fl
uid
resuscit
per
sepsi
guidelin
point
within
h
attempt
fl
uid
resuscit
vasopressor
therapi
indic
shown
improv
mortal
intens
insulin
therapi
fl
uid
resuscit
colloid
recommend
critic
ill
past
howev
recent
trial
fail
show
defi
nitiv
benefi
therapi
sever
sepsi
intens
insulin
therapi
increas
risk
hypoglycemia
shown
improv
mortal
acut
set
sepsi
delling
rp
levi
mm
carlet
jm
et
al
surviv
sepsi
campaign
intern
guidelin
manag
sever
sepsi
septic
shock
crit
care
med
clinic
outcom
reduc
use
chlorhexidin
bath
compar
soap
water
bath
icu
patient
global
infect
rate
b
ventilatorassoci
pneumonia
vap
rate
c
catheterassoci
urinari
tract
infect
cauti
rate
answer
answer
correct
bath
chlorhexidineimpregn
wipe
associ
global
specifi
c
infect
rate
reduct
studi
icu
patient
compar
soap
water
bath
true
concern
postop
cognit
dysfunct
pocd
pocd
less
like
occur
oper
region
anesthesia
gener
anesthesia
b
like
major
minor
oper
c
like
cardiac
surgeri
type
surgeri
like
age
younger
patient
e
answer
e
risk
pocd
increas
age
type
durat
surgeri
low
incid
among
age
group
associ
minor
surgeri
pocd
common
adult
patient
age
hospit
discharg
major
noncardiac
surgeri
elderli
age
year
older
signifi
cant
risk
longterm
cognit
problem
may
last
long
month
becom
perman
rasmussen
ls
postop
cognit
dysfunct
incid
prevent
best
practic
research
clin
anaesthesiol
femal
aid
admit
failur
thrive
experienc
chronic
diarrhea
anorexia
famili
struggl
get
eat
bite
per
day
obviou
opportunist
infect
famili
distress
caus
continu
declin
appear
lack
oral
intak
request
home
iv
nutrit
establish
physic
exam
temperatur
heart
rate
bpm
blood
pressur
mmhg
respiratori
rate
breathsmin
height
weight
kg
appear
chronic
ill
bitempor
wast
hair
thin
follow
statement
regard
home
total
parenter
nutrit
tpn
true
surviv
qualiti
life
improv
patient
metastat
cancer
receiv
home
tpn
b
surviv
qualiti
life
improv
patient
aid
receiv
home
tpn
c
surviv
qualiti
life
improv
patient
short
bowel
crohn
diseas
receiv
home
tpn
evid
support
use
home
tpn
answer
c
mean
surviv
aid
patient
metastat
cancer
receiv
home
tpn
failur
thrive
month
evid
home
tpn
prolong
life
improv
qualiti
life
patient
home
tpn
expens
indic
select
circumst
patient
short
bowel
result
treatment
crohn
diseas
pseudoobstruct
good
respons
home
tpn
patient
tpn
increas
qualityadjust
year
life
patient
costeffect
littl
evid
support
use
home
tpn
chronic
diseas
result
malnutrit
man
ischem
heart
failur
new
york
heart
associ
nyha
function
class
iv
sever
chronic
obstruct
pulmonari
diseas
admit
icu
cardiac
decompens
third
admiss
past
month
diffi
culti
activ
daili
live
patient
current
medic
carvedilol
lisinopril
spironolacton
furosemid
beta
agonist
inhal
previous
taken
warfarin
aspirin
signifi
cant
bleed
gastric
ulcer
week
prior
admiss
prompt
discontinu
two
year
ago
automat
implant
cardiovert
defi
brillat
aicd
place
transven
approach
persist
ventricular
arrhythmia
past
week
aicd
fi
red
six
time
patient
daughter
report
sinc
last
hospit
discharg
patient
spent
time
sleep
reclin
bed
poor
appetit
physic
examin
patient
dyspneic
poorli
commun
deni
current
chest
pain
follow
correct
treatment
initi
milrinon
infus
b
angiographi
possi
ble
percutan
intervent
c
insert
intraaort
balloon
pump
deactiv
aicd
e
aicd
recalibr
answer
patient
multipl
indic
defi
nition
advanc
chronic
heart
failur
includ
symptombas
high
new
york
heart
associ
nyha
classifi
cation
sever
chronic
obstruct
pulmonari
diseas
left
ventricular
eject
fraction
palli
care
appropri
offer
reason
intervent
time
deactiv
automat
implant
cardiovert
defi
brillat
aicd
failur
deactiv
aicd
leav
mani
patient
vulner
inappropri
devic
discharg
unnecessari
discomfort
intens
anxieti
measur
infus
posit
inotrop
use
temporari
basi
plan
defi
nitiv
therapi
use
intermitt
infus
control
symptom
recommend
ahaacc
guidelin
unless
patient
await
defi
nitiv
therapi
transplant
man
admit
larg
subarachnoid
hemorrhag
sah
ruptur
cerebr
aneurysm
spontan
movement
past
week
remain
intub
concern
patient
brain
death
test
commonli
use
diagnos
brain
death
situat
cerebr
angiographi
b
apnea
test
c
demonstr
absent
cranial
nerv
refl
exe
demonstr
fi
xed
dilat
pupil
e
perform
transcrani
doppler
ultrasonographi
answer
b
brain
death
defi
ned
lack
cerebr
function
continu
cardiac
activ
state
requir
support
artifici
mean
individu
determin
brain
death
lifesustain
therapi
may
withdrawn
occur
without
consent
famili
import
ongo
commun
famili
allow
withdraw
care
without
confl
ict
hospit
develop
specifi
c
protocol
line
state
law
diagnos
patient
brain
death
three
element
demonstr
diagnosi
brain
death
patient
widespread
cortic
damag
complet
absenc
respons
extern
stimuli
second
patient
evid
medullari
function
demonstr
lack
oculovestibular
corneal
refl
exe
common
test
assess
pupillari
reaction
light
final
evid
medullari
activ
manifest
apnea
specifi
c
protocol
develop
perform
apnea
test
allen
la
stevenson
lw
gradi
kl
et
al
aha
scientifi
c
statement
decis
make
advanc
heart
failur
circul
wijdick
efm
diagnosi
brain
death
n
engl
j
med
woman
admit
sever
nausea
diarrhea
complain
nausea
diarrhea
began
earli
afternoon
report
ate
sandwich
street
vendor
lunch
began
experienc
symptom
sever
hour
later
report
similar
experi
past
recent
travel
histori
contact
sick
person
treat
cours
ciprofl
oxacin
urinari
tract
infect
month
ago
otherwis
healthi
physic
exam
heme
neg
abdomen
mildli
tender
afebril
organ
like
caus
patient
acut
diarrheal
ill
campylobact
jejuni
b
salmonella
enteritidi
c
staphylococcu
aureu
c
diffi
cile
e
e
coli
answer
c
acut
diarrhea
caus
viral
infect
adeno
norwalk
rotaviru
selflimit
caus
bacteria
common
agent
urban
area
campylobact
salmonella
shigella
escherichia
coli
protozoa
giardia
lamblia
entamoeba
histolytica
account
common
caus
one
mechan
acut
diarrhea
ingest
preform
toxin
sever
speci
bacteria
aureu
c
perfringen
bacillu
cereu
produc
toxin
produc
syndrom
commonli
design
food
poison
occur
within
h
ingest
case
bacteria
need
establish
intralumin
infect
ingest
toxin
alon
produc
diseas
symptom
subsid
toxin
clear
usual
next
day
symptom
usual
local
fever
minim
femal
histori
renal
transplant
year
prior
present
headach
fever
purul
rhinorrhea
occur
past
day
steroid
intermitt
past
month
episod
acut
reject
physic
exam
letharg
abl
respond
question
appropri
lung
clear
auscult
diffus
maxillari
tender
note
black
nasal
discharg
follow
like
caus
ill
coccidioid
immiti
b
rhizopu
mucormycosi
c
histoplasmosi
capsulatum
blastomyc
dermatitidi
e
cryptococcu
neoforman
answer
b
patient
symptom
consist
mucormycosi
invas
fungal
infect
caus
varieti
fungi
commonli
rhizopu
rapid
opportunist
infect
invad
vascular
system
lifethreaten
condit
urgent
consult
otolaryngolog
infecti
diseas
warrant
mucormycosi
acquir
inhal
spore
found
ubiquit
soil
decay
fruit
old
bread
although
black
eschar
classic
fi
nding
mucormycosi
present
less
half
patient
presenc
black
eschar
indic
vascular
invas
predict
poor
prognosi
prognosi
mucormycosi
poor
vari
mortal
rate
depend
form
sever
patient
immunocompromis
signifi
cantli
higher
mortal
rate
rhinocerebr
form
mortal
rate
dissemin
mucormycosi
poor
prognosi
mortal
rate
male
past
medic
histori
diabet
mellitu
ii
hypertens
hypothyroid
esrd
hemodialysi
day
per
week
present
right
leg
swell
leg
pain
imag
confi
rm
lower
extrem
deep
vein
thrombosi
dvt
patient
want
know
treatment
option
besid
warfarin
state
grandma
bled
much
drug
attend
physician
explain
choic
rivaroxaban
b
dabigatran
c
warfarin
heparin
bridg
minimum
day
answer
c
sever
altern
coumadin
treatment
dvt
import
know
advantag
disadvantag
patient
hemodialysi
limit
medic
option
dvt
treatment
rivaroxaban
avoid
crcl
mlmin
dabigatran
studi
hd
patient
patient
crcl
mlmin
popul
exclud
dvtpe
trial
howev
warfarin
requir
renal
adjust
safe
use
hd
patient
appropri
monitor
inr
femal
present
newonset
right
hemiplegia
ct
scan
perform
found
larg
leftsid
middl
cerebr
arteri
stroke
past
medic
histori
signifi
cant
hypertens
diabet
hospit
cours
unev
prior
transfer
skill
nurs
facil
patient
initi
physic
therapi
make
good
progress
good
famili
support
anticip
admiss
skill
nurs
facil
live
home
medic
assist
histori
depress
psychiatr
disord
patient
famili
state
extrem
activ
lifestyl
event
concern
develop
depress
notic
seem
bit
time
request
antidepress
start
treatment
prevent
depress
follow
appropri
advic
famili
incid
depress
therefor
therapi
recommend
b
incid
depress
poststrok
therapi
recommend
c
incid
depress
lowdos
select
serotonin
reuptak
inhibitor
would
reason
choic
incid
depress
poststrok
lowdos
select
serotonin
reuptak
inhibitor
would
reason
choic
answer
b
incid
mild
dysthym
state
common
incid
stroke
due
loss
prior
function
possibl
due
chemic
chang
seen
cerebr
cortex
durat
condit
may
last
sever
week
lifetim
preval
depress
stroke
cumul
incid
within
year
stroke
appear
metaanalysi
perform
reveal
defi
nitiv
benefi
pharmacolog
therapi
prevent
depress
stroke
small
statist
signifi
cant
benefi
psychotherapi
appropri
approach
would
advis
patient
famili
follow
sign
depress
consid
treatment
diagnosi
becom
appar
patient
current
sign
depress
appropri
sign
griev
loss
function
linezolid
follow
characterist
compar
vancomycin
decreas
nephrotox
higher
dose
b
increas
intrapulmonari
penetr
c
increas
incid
thrombocytopenia
e
none
answer
answer
correct
vancomycin
current
main
stay
methicillinresist
staphylococcu
aureu
mrsa
infect
newer
agent
see
increas
use
due
better
side
effect
profi
le
tissu
penetr
linezolid
may
prefer
treat
nosocomi
pneumonia
due
mrsa
addit
confi
rming
patient
ident
verbal
note
site
procedur
follow
joint
commiss
identifi
ed
critic
compon
timeout
univers
protocol
invas
procedur
patient
admit
diagnosi
b
patient
date
birth
c
type
procedur
patient
age
date
admiss
e
followup
plan
procedur
answer
c
joint
commiss
defi
ned
sever
critic
compon
timeout
effort
improv
patient
safeti
reduc
medic
error
compon
must
perform
prior
procedur
includ
confi
rming
patient
ident
site
procedur
type
procedur
prepar
discharg
retir
nurs
inpati
servic
hospit
heart
failur
two
admiss
year
patient
long
histori
hypertens
heart
failur
prior
admiss
report
weight
gain
peripher
edema
decreas
exercis
toler
day
hospit
patient
given
intraven
furosemid
mg
iv
bid
good
respons
admiss
medic
amlodipin
mg
daili
carvedilol
mg
twice
daili
furosemid
mg
daili
aspirin
mg
daili
suspect
compliant
medic
diet
day
discharg
blood
pressur
mmhg
heart
rate
bpm
serum
sodium
meql
serum
creatinin
mg
dl
electrocardiogram
demonstr
normal
sinu
rhythm
increas
voltag
precordi
lead
leftaxi
deviat
transthorac
echocardiogram
show
left
ventricular
eject
fraction
mildli
thicken
left
ventricl
enlarg
left
atrium
follow
next
increas
amlodipin
dosag
mg
daili
b
increas
furosemid
dosag
mg
twice
daili
c
add
digoxin
mg
daili
add
lisinopril
mg
daili
e
increas
carvedilol
mg
twice
daili
answer
patient
respond
diuresi
may
need
intervent
prevent
exacerb
congest
heart
failur
heart
failur
normal
left
ventricl
eject
fraction
hfnef
preval
among
older
women
histori
hypertens
mainstay
treatment
includ
blood
pressur
manag
rate
control
lowsalt
diet
weight
loss
exercis
attempt
reinforc
pair
observ
studi
demonstr
associ
discharg
prescript
angiotensinconvert
enzym
ace
inhibitor
lower
overal
mortal
among
patient
hfnef
patient
would
seem
reason
cautious
add
ace
inhibitor
increas
furosemid
dosag
might
exacerb
possibl
volum
deplet
male
present
progress
short
breath
past
month
packyear
histori
smoke
ct
scan
chest
reveal
right
middl
lobe
mass
subsequ
undergo
biopsi
reveal
adenocarcinoma
magnet
reson
imag
brain
reveal
cm
tumor
left
cerebr
cortex
consist
metastat
diseas
patient
histori
seizur
syncop
patient
refer
outpati
therapi
hematologyoncolog
servic
well
followup
radiat
oncolog
patient
readi
discharg
follow
would
appropri
therapi
primari
seizur
prevent
seizur
prophylaxi
indic
b
valproat
c
phenytoin
phenobarbit
e
oral
prednison
mg
daili
answer
indic
antiepilept
therapi
primari
prevent
patient
brain
metastasi
undergon
resect
past
studi
reveal
differ
seizur
rate
placebo
antiepilept
therapi
patient
brain
tumor
antiepilept
therapi
high
rate
advers
reaction
caution
exercis
use
man
admit
dedic
geriatr
acut
care
unit
home
treatment
nausea
vomit
relat
urinari
tract
infect
unit
staf
limit
group
train
provid
outcom
geriatr
patient
assum
better
unit
follow
statement
accur
character
benefi
ts
geriatr
acut
care
unit
gener
inpati
ward
geriatr
acut
care
unit
reduc
inhospit
function
declin
b
patient
receiv
care
geriatr
acut
care
unit
improv
function
statu
month
discharg
c
geriatr
acut
care
unit
provid
patientcent
care
emphas
independ
increas
likelihood
patient
receiv
care
geriatr
acut
care
unit
abl
return
home
upon
discharg
e
geriatr
acut
care
unit
provid
intens
review
medic
care
minim
advers
effect
medic
answer
day
discharg
function
capac
geriatr
unit
nonspeci
acut
care
unit
geriatr
unit
special
prepar
environ
specifi
c
protocol
enhanc
discharg
plan
medic
care
design
minim
advers
effect
procedur
medic
geriatr
unit
one
sever
model
comprehens
inpati
geriatr
care
develop
geriatrician
research
address
advers
event
function
declin
often
accompani
hospit
despit
assum
benefi
ts
studi
far
mix
sever
shortterm
favor
outcom
record
includ
reduct
declin
shortterm
function
readmiss
longterm
endpoint
yet
demonstr
care
transit
discharg
includ
coordin
followup
care
commun
patient
transfer
locat
level
care
time
medic
error
patient
harm
known
like
due
increas
fi
nancial
incent
mani
studi
current
look
readmiss
prevent
strategi
yet
singl
factor
identifi
ed
primari
factor
readmiss
prevent
follow
contraind
herp
zoster
vaccin
age
younger
year
b
chronic
postherpet
neuralgia
c
histori
shingl
lymphoma
e
histori
varicella
infect
answer
advisori
committe
immun
practic
acip
recommend
herp
zoster
vaccin
routin
recommend
adult
age
acip
state
peopl
primari
acquir
immunodefi
cienci
receiv
vaccin
immunodefi
cient
state
lymphoma
aid
leukemia
constitut
absolut
contraind
receiv
herp
zoster
vaccin
center
diseas
control
prevent
acip
recommend
adult
vaccin
whether
report
previou
episod
herp
zoster
remain
larg
popul
mildli
moder
immunocompromis
patient
riskbenefi
ratio
vaccin
well
understood
man
evalu
hospit
patient
admit
yesterday
treatment
acut
pancreat
secondari
alcohol
abus
remain
symptomat
h
physic
examin
lie
side
knee
drawn
chest
vital
sign
includ
temperatur
blood
pressur
mmhg
puls
rate
beatsmin
respiratori
rate
breathsmin
oxygen
satur
ambient
air
oral
mucosa
dri
abdomin
examin
disclos
decreas
bowel
sound
epigastr
tender
remaind
examin
normal
leukocyt
count
hematocrit
blood
urea
nitrogen
mgdl
creatinin
mg
dl
amylas
ul
abdomin
ultrasonographi
show
gallston
dilat
common
bile
duct
follow
predict
poor
outcom
patient
amylas
level
b
anemia
c
blood
urea
nitrogen
level
leukocytosi
e
age
answer
c
hemoconcentr
measur
best
predictor
higher
morbid
mortal
patient
acut
pancreat
includ
elev
blood
urea
nitrogen
serum
creatinin
hematocrit
level
multipl
score
system
devis
measur
outcom
patient
acut
pancreat
tradit
util
ranson
criteria
reli
paramet
measur
admiss
h
acut
physiolog
chronic
health
evalu
ii
score
accur
ranson
criteria
hemoconcentr
may
serv
marker
capillari
leak
acut
pancreat
may
explain
correl
mortal
patient
sever
diseas
tend
elev
level
blood
urea
nitrogen
serum
creatinin
hematocrit
factor
blood
urea
nitrogen
level
accur
predict
sever
factor
predispos
patient
poor
prognosi
medic
comorbid
age
greater
year
increas
bodymass
index
correl
degre
elev
serum
amylas
level
sever
prognosi
ill
patient
acut
pancreat
mild
moder
leukocytosi
common
patient
acut
pancreat
prognost
signifi
canc
follow
therapi
sever
acut
respiratori
distress
syndrom
ard
strongest
evid
improv
surviv
larg
random
studi
steroid
b
highfrequ
oscil
ventil
c
prone
posit
nebul
betaadrenerg
agonist
therapi
e
antibiot
prone
posit
may
improv
oxygen
patient
acut
respiratori
distress
syndrom
ard
sever
studi
examin
strategi
improv
outcom
ard
limit
posit
result
recent
larg
studi
patient
found
mark
reduct
patient
treat
prone
posit
complic
differ
two
treatment
except
higher
incid
cardiac
arrest
supin
patient
group
anoth
larg
random
trial
show
potenti
harm
increas
mortal
earli
use
highfrequ
oscil
ard
patient
ard
network
trial
nebul
betaadrenerg
agonist
therapi
fail
show
benefi
oxygen
satur
room
air
patient
anxiou
alert
orient
person
place
time
physic
examin
show
abnorm
heart
lung
laboratori
studi
cardiac
enzym
level
within
normal
limit
electrocardiographi
chest
xray
studi
show
abnorm
base
well
criteria
follow
best
repres
probabl
pulmonari
embol
patient
low
b
intermedi
c
high
none
answer
patient
low
well
criteria
probabl
pulmonari
embol
well
criteria
use
determin
pretest
probabl
pulmonari
embol
patient
base
histori
physic
examin
well
criteria
allow
clinician
determin
patient
need
diagnost
invas
test
well
criteria
assign
point
presenc
sign
symptom
histor
factor
includ
tachycardia
hemoptysi
deep
venou
thrombosi
addit
point
assign
histori
venou
thromboembol
activ
malign
recent
immobil
surgeri
well
criteria
assign
point
altern
diagnosi
like
patient
histor
factor
clinic
fi
nding
suggest
pulmonari
embol
well
score
symptom
could
relat
musculoskelet
pain
pleurisi
anxieti
answer
e
although
wide
measur
benefi
ts
bnp
measur
clinic
qualiti
endpoint
remain
uncertain
metaanalysi
measur
effect
bnp
test
clinic
outcom
patient
present
emerg
depart
short
breath
reveal
bnp
test
led
decreas
admiss
rate
decreas
mean
length
stay
effect
allcaus
hospit
mortal
seen
bnp
test
use
aid
diagnosi
assess
sever
heart
failur
bnp
test
also
use
risk
stratifi
cation
patient
acut
coronari
syndrom
bnp
valu
may
fl
uctuat
due
factor
heart
failur
lower
predict
level
often
seen
obes
patient
higher
level
seen
renal
diseas
absenc
heart
failur
suggest
one
import
use
natriuret
peptid
help
establish
diagnosi
heart
failur
hf
diagnosi
uncertain
patient
valu
less
make
hf
unlik
valu
greater
make
hf
like
femal
admit
nurs
home
diagnosi
urinari
tract
infect
sepsi
histori
progress
dementia
known
implant
devic
orthoped
intern
hardwar
blood
cultur
drawn
reveal
gramposit
rod
otherwis
sourc
infect
isol
urin
cultur
neg
fi
rst
h
clinic
improv
back
baselin
mental
statu
follow
explain
posit
blood
cultur
urinari
tract
infect
b
endocard
c
skin
contamin
chronic
wound
infect
answer
c
four
bacteria
common
contamin
blood
cultur
posit
coagulaseneg
staph
gramposit
cocci
corynebacterium
gramposit
rod
propionibacterium
acn
anaerob
gramposit
rod
bacillu
speci
anaerob
gramposit
rod
may
consid
true
pathogen
multipl
site
posit
patient
prosthet
implant
staphylococcu
aureu
streptococcu
speci
enterococcu
candida
pseudomona
gramneg
rodsposit
bacillu
usual
contamin
skin
particular
case
without
sign
overwhelm
sepsi
gramposit
rod
almost
certainli
contamin
betablock
provid
follow
benefi
ts
elderli
patient
congest
heart
failur
preserv
eject
fraction
decreas
allcaus
mortal
b
decreas
heart
failur
rehospit
c
none
answer
betablock
essenti
treatment
chf
reduc
eject
fraction
howev
patient
chf
preserv
eject
fraction
benefi
ts
demonstr
studi
year
patient
age
associ
individu
endpoint
allcaus
mortal
heart
failur
rehospit
use
betablock
discharg
answer
common
advers
event
hospit
patient
advers
drug
event
ade
occur
approxim
hospit
advers
event
defi
ned
injuri
caus
medic
manag
rather
underli
diseas
patient
recent
year
increas
focu
safeti
health
care
provid
throughout
world
institut
medicin
report
identifi
ed
safeti
essenti
compon
qualiti
health
care
one
largest
studi
attempt
quantifi
advers
event
hospit
patient
harvard
medic
practic
studi
studi
advers
event
includ
ade
wound
infect
technic
complic
procedur
diagnost
mishap
fall
round
pharmacist
shown
greatli
reduc
prevent
advers
drug
event
one
studi
fewer
prevent
advers
drug
event
ade
occur
among
patient
pharmacist
particip
weekday
medic
round
answer
e
hepatoren
syndrom
hr
develop
spontan
trigger
precipit
event
type
hr
character
rapidli
progress
kidney
failur
doubl
serum
creatinin
level
greater
mgdl
halv
creatinin
clearanc
less
mlmin
period
less
week
common
precipit
trigger
type
hepatoren
hr
syndrom
spontan
bacteri
periton
consid
endstag
liver
diseas
esld
patient
hepatoren
syndrom
import
consid
even
absenc
symptom
type
hr
occur
approxim
patient
sbp
despit
rapid
resolut
infect
antibiot
hepatoren
syndrom
primarili
induc
renal
arteri
vasoconstrict
sever
condit
decreas
renal
blood
fl
ow
also
induc
type
hepatoren
syndrom
includ
sepsi
volum
deplet
volum
shift
may
occur
largevolum
paracentesi
undertaken
adequ
plasma
expans
undertaken
largevolum
paracentesi
occur
betrosian
ap
agarw
b
douzina
ee
acut
renal
dysfunct
liver
diseas
world
j
gastroenterol
femal
admit
hospit
medicin
servic
possibl
osteomyel
past
medic
histori
includ
hypertens
diabet
mellitu
type
depress
hyperlipidemia
lab
within
normal
limit
except
elev
wbc
count
medic
admiss
order
complet
emerg
room
physician
order
pantoprazol
mg
po
daili
stress
ulcer
prophylaxi
pantoprazol
indic
patient
ye
b
answer
b
prophylact
proton
pump
inhibitor
therapi
recommend
follow
major
risk
factor
respiratori
failur
requir
mechan
ventil
like
greater
h
coagulopathi
defi
ned
platelet
count
inr
ptt
control
prophylact
treatment
dose
anticoagul
constitut
coagulopathi
addit
risk
factor
warrant
stress
ulcer
prophylaxi
follow
head
spinal
cord
injuri
sever
burn
bsa
acut
organ
dysfunct
histori
gi
ulcerbleed
within
year
high
dose
corticosteroid
liver
failur
associ
coagulopathi
postop
transplant
acut
kidney
injuri
major
surgeri
multipl
trauma
suppress
acid
product
stomach
may
lead
advers
side
effect
increas
risk
aspir
pneumonia
guidelin
stress
ulcer
prophylaxi
j
health
syst
pharm
sessler
jm
stressrel
mucos
diseas
intens
care
unit
updat
prophylaxi
aacn
adv
crit
care
unit
medic
director
ask
hospit
administr
align
current
cardiac
code
polici
evidencebas
guidelin
particular
ask
reduc
variabl
current
occur
follow
would
suggest
increas
frequenc
advanc
cardiovascular
life
support
acl
train
becom
annual
requir
clinic
practition
b
interview
hospit
staff
use
delphi
method
process
enumer
optim
resuscit
practic
c
develop
resuscitationspecifi
c
privileg
requir
hospit
credenti
implement
american
heart
associ
aha
get
guidelin
resuscit
program
answer
american
heart
associ
aha
put
great
deal
effort
expertis
develop
evidencebas
guidelin
cardiac
resuscit
aha
get
guidelin
program
develop
identifi
improv
opportun
allow
perform
comparison
among
hospit
reduc
medic
error
datadriven
peer
review
aha
review
uptod
research
scientifi
c
public
develop
program
program
includ
guidelin
resuscit
atrial
fi
brillat
heart
failur
stroke
us
govern
nation
qualiti
forumapprov
methodolog
calcul
excess
readmiss
rate
includ
follow
except
adjust
clinic
relev
patient
comorbid
b
patient
socioeconom
statu
specifi
calli
feder
defi
ned
incom
level
poverti
line
c
establish
period
discharg
calcul
readmiss
caus
anoth
hospit
patient
specifi
ed
diagnos
e
minimum
number
case
annual
hospit
list
answer
b
thirtyday
hospit
readmiss
common
costli
may
signal
unnecessari
use
resourc
focu
us
health
polici
intervent
reduc
cost
march
comprehens
health
reform
act
patient
protect
afford
care
act
went
law
law
establish
program
encourag
reduct
hospit
readmiss
requir
us
center
medicar
medicaid
servic
reduc
payment
hospit
excess
readmiss
thirtyday
hospit
readmiss
calcul
consid
socioeconom
statu
race
ethnic
english
languag
profi
cienci
risk
adjust
strong
risk
factor
readmiss
hospit
advoc
feel
factor
clinician
control
consid
penalti
determin
follow
statement
true
compar
dopamin
norepinephrin
fi
rstline
vasotherapi
septic
shock
increas
overal
death
rate
b
increas
death
rate
among
septic
shock
group
c
increas
arrhythmia
increas
use
addit
vasopressor
answer
c
although
longstand
debat
singl
vasopressor
defi
nitiv
shown
mortal
benefi
anoth
patient
septic
shock
help
better
answer
question
whether
mortal
benefi
initi
vasopressor
use
sepsi
occurr
acut
ill
patient
ii
soap
ii
studi
random
patient
shock
norepinephrin
dopamin
initi
vasopressor
studi
found
differ
two
group
mortal
although
significantli
cardiac
arrhythmia
dopamin
group
femal
present
confus
diaphoresi
mild
short
breath
rapidli
perform
ekg
reveal
possibl
ischemia
common
symptom
acut
myocardi
infarct
patient
older
year
old
chest
pain
b
alter
mental
statu
c
syncop
dyspnea
e
fever
answer
patient
older
year
age
short
breath
common
symptom
myocardi
infarct
may
due
acut
congest
heart
failur
anxieti
elderli
diabet
femal
patient
often
atyp
angin
symptom
initi
evalu
elderli
patient
suspect
myocardi
ischemia
begin
high
index
suspicion
atyp
symptom
answer
b
concern
azithromycin
may
increas
risk
ventricular
arrhythmia
suscept
adult
databas
analysi
found
increas
arrhythmia
cardiovascular
event
patient
treat
azithromycin
found
associ
clarithromycin
ciprofl
oxacin
advers
cardiac
outcom
mani
author
suggest
older
individu
high
risk
cardiovascular
diseas
may
vulner
advers
effect
use
extra
caution
take
antibiot
also
suggest
inappropri
use
led
widespread
antibiot
resist
contribut
emerg
resist
bacteria
azithromycin
develop
market
unit
state
sinc
commonli
prescrib
antibiot
answer
report
bia
continu
major
problem
assess
healthcar
intervent
sever
promin
case
report
public
bia
describ
literatur
includ
trial
report
effect
antidepress
class
antiarrhythm
drug
select
inhibitor
studi
drug
shown
ineffect
often
publish
delay
modifi
ed
emphas
posit
result
suggest
addit
trial
statist
signifi
cant
fi
nding
gener
publish
academ
journal
higher
circul
often
trial
nonsignifi
cant
fi
nding
gener
publish
evid
tend
overestim
effi
caci
underestim
safeti
risk
extent
often
unknown
picc
reliabl
altern
shortterm
central
venou
cathet
lower
risk
complic
picc
higher
patient
satisfact
lower
infect
rate
costeffect
cvc
howev
picc
associ
higher
risk
deep
vein
thrombosi
central
venou
cathet
cvc
risk
increas
patient
critic
ill
malign
also
meet
defi
nition
picc
distal
tip
cathet
must
termin
superior
vena
cava
inferior
vena
cava
proxim
right
atrium
thrombosi
may
result
picc
insert
peripher
vein
narrow
like
occlud
presenc
cathet
larg
vein
use
cvc
reduc
readmiss
rate
major
prioriti
hospit
given
afford
care
act
aca
establish
hospit
readmiss
reduct
program
requir
center
medicar
medicaid
servic
cm
reduc
payment
hospit
excess
readmiss
readmiss
avoid
unplan
readmiss
frequent
suggest
breakdown
continu
care
unsuccess
transit
care
set
studi
suggest
readmiss
usual
tie
medic
error
commit
hospit
stay
rather
social
issu
poor
followup
patient
lack
understand
posthospit
care
reduc
readmiss
proven
diffi
cult
simpl
fi
x
found
gain
seen
institut
employ
multifactori
approach
man
present
pain
swell
right
knee
swell
sever
fi
nger
otherwis
healthi
recal
sever
bout
diarrheal
ill
week
prior
spontan
resolv
take
medic
report
rare
marijuana
use
physic
exam
limit
motion
swell
right
knee
suspect
reactiv
arthriti
due
diarrheal
ill
follow
like
etiolog
agent
diarrhea
answer
e
common
organ
associ
reactiv
arthriti
diarrheal
ill
shigella
speci
reactiv
arthriti
refer
acut
nonpurul
arthriti
occur
infect
elsewher
bodi
shigella
infect
often
present
lower
joint
infl
ammatori
arthriti
occur
week
diarrheal
episod
reactiv
arthriti
may
also
includ
uveiti
conjunct
dactyl
urogenit
lesion
occur
yersinia
chlamydia
much
lesser
extent
salmonella
campylobact
nurs
home
resid
admit
melena
call
see
fi
rst
night
found
unrespons
bed
immers
black
stool
past
medic
histori
remark
alzheim
dementia
physic
pressur
mmhg
heart
rate
beatsmin
transfer
icu
central
venou
cathet
place
reveal
cvp
less
mmhg
catheter
bladder
yield
urin
anesthesiolog
call
bedsid
assess
patient
airway
patient
describ
follow
true
regard
clinic
condit
loss
blood
volum
lead
shock
physiolog
b
loss
less
blood
volum
manifest
orthostasi
c
oliguria
prognost
sign
impend
vascular
collaps
symptom
hypovolem
shock
differ
hemorrhag
shock
e
fi
rst
sign
hypovolem
shock
mental
obtund
answer
c
oliguria
import
clinic
paramet
help
guid
volum
resuscit
volum
resuscit
initi
rapid
iv
infus
isoton
salin
ringer
lactat
assess
adequ
airway
spontan
breath
initi
resuscit
aim
reexpand
intravascular
volum
control
ongo
loss
transfus
pack
red
blood
cell
prbc
consid
hemorrhag
shock
continu
blood
loss
hemoglobin
less
gdl
symptom
hemorrhag
nonhemorrhag
shock
indistinguish
blood
volum
lost
clinic
symptom
except
mild
tachycardia
orthostasi
seen
loss
blood
volum
shock
occur
loss
blood
volum
result
mark
tachycardia
hypotens
oliguria
fi
nalli
obtund
central
nervou
system
perfus
maintain
shock
becom
sever
hemorrhag
control
transfus
prbc
perform
hemoglobin
gdl
less
patient
remain
hypotens
volum
resuscit
poor
prognosi
inotrop
support
intens
monitor
initi
patient
follow
circumst
would
albumin
infus
benefi
cial
patient
endstag
liver
diseas
ascit
requir
paracentesi
b
patient
hypotens
serum
albumin
gdl
c
patient
acut
blood
loss
await
type
match
pack
red
blood
cell
infus
patient
hypotens
sepsi
syndrom
serum
albumin
gdl
answer
role
albumin
infus
remain
uncertain
mani
clinic
situat
albumin
compos
blood
plasma
protein
effect
prevent
complic
highvolum
paracentesi
patient
cirrhosi
ascit
undergo
paracentesi
indic
use
albumin
administr
critic
ill
patient
uncertain
gener
albumin
given
specifi
calli
treat
hypoalbuminemia
marker
seriou
diseas
known
histori
alcohol
ascit
hepat
encephalopathi
ammonia
upon
admiss
elev
husband
claim
take
lactulos
often
prescrib
also
report
bowel
movement
per
day
upon
admiss
lactulos
restart
g
po
tid
day
hospit
patient
alert
closer
baselin
per
husband
nurs
chart
follow
bowel
movement
day
day
day
far
lactulos
work
set
hepat
encephalopathi
decreas
amount
ammoniaproduc
bacteria
gut
b
creat
acid
ph
gut
turn
caus
becom
result
osmot
effect
gut
due
nonabsorb
ammonium
ion
c
creat
resin
ammonia
bind
excret
fecal
work
stimul
lax
answer
b
option
describ
mechan
action
rifaximin
option
c
incorrect
resin
form
lactulos
option
incorrect
lactulos
work
osmot
rather
stimul
alsnielsen
b
gluud
gluud
c
nonabsorb
disaccharid
hepat
encephalopathi
systemat
review
randomis
trial
bmj
man
admit
cellul
respond
antibiot
readi
discharg
would
like
get
warfarin
start
six
month
ago
atrial
fi
brillat
underw
ablat
month
ago
longstand
atrial
fi
brillat
symptom
palpit
sinc
hypertens
type
diabet
mellitu
medic
lisinopril
atenolol
insulin
warfarin
blood
pressur
mmhg
puls
rate
beatsmin
cardiac
examin
ekg
disclos
regular
rate
rhythm
rest
physic
examin
normal
follow
appropri
treatment
continu
warfarin
b
switch
aspirin
c
switch
clopidogrel
switch
aspirin
clopidogrel
e
h
halter
monitor
answer
warfarin
continu
indefi
nite
patient
patient
atrial
fi
brillat
ablat
take
warfarin
month
best
manag
strategi
provid
anticoagul
ablat
occur
tool
score
commonli
use
guid
therapi
option
although
patient
symptom
atrial
fi
brillat
sinc
ablat
procedur
warfarin
still
indic
hypertens
diabet
mellitu
give
patient
score
two
risk
stroke
per
year
score
zero
aspirin
alon
prefer
agent
new
agent
dabigatran
rivaroxaban
may
option
agent
studi
postatri
fi
brillat
ablat
set
recent
return
africa
spend
month
medic
mission
emerg
isol
procedur
activ
remain
ill
develop
worsen
symptom
odynophagia
sore
throat
conjunct
diagnos
ebola
viru
final
develop
dissemin
intravascular
coagul
mucos
bleed
alter
mental
statu
anuria
die
day
later
emerg
room
nurs
may
expos
patient
bodili
fl
uid
long
nurs
follow
sign
ebola
infect
day
b
day
c
day
day
answer
b
center
diseas
control
prevent
recommend
peopl
possibl
ebola
exposur
receiv
medic
evalu
close
followup
care
includ
fever
monitor
twice
daili
day
last
known
exposur
contact
trace
shown
effect
case
follow
day
exposur
effect
limit
outbreak
worldwid
rural
area
move
expos
patient
symptom
home
commun
design
area
isol
also
proven
success
control
effort
suggest
expos
health
care
personnel
medic
follow
day
sign
symptom
ebola
viru
follow
patient
group
would
adequ
treat
pneumonia
util
ceftriaxon
azithromycin
therapi
upon
present
emerg
depart
femal
attend
dialysi
tuesday
thursday
saturday
b
male
undergo
chemotherapi
acut
leukemia
c
femal
histori
hypertens
glaucoma
never
hospit
male
resid
nurs
home
due
earlyonset
dementia
answer
c
major
hospit
patient
communityacquir
pneumonia
treat
either
respiratori
fluoroquinolon
combin
cephalosporin
macrolid
current
durat
treatment
recommend
total
therapi
cours
import
physician
assess
patient
increas
risk
bacteri
resist
empir
antibiot
regimen
patient
meet
criteria
healthcareassoci
pneumonia
identifi
antibiot
regimen
may
need
includ
coverag
methicillinresist
staphylococcu
aureu
mrsa
multidrugresist
mdr
gramneg
pathogen
man
admit
nurs
home
stroke
week
ago
patient
residu
rightsid
paralysi
aphasia
urinari
incontin
respond
verbal
command
speak
well
enough
make
need
known
spend
day
bed
chair
expect
physic
progress
slow
need
assist
activ
daili
live
patient
poor
appetit
use
right
arm
feed
eat
half
meal
also
intermitt
urinari
incontin
current
skin
breakdown
follow
appropri
intervent
prevent
pressur
ulcer
patient
airfl
uidiz
bed
b
doughnut
cushion
seat
c
foam
mattress
overlay
bladder
catheter
e
massag
skin
pressur
answer
c
patient
mani
risk
factor
pressur
ulcer
includ
advanc
age
reduc
mobil
poor
nutrit
urinari
incontin
appropri
costeffect
prevent
measur
patient
foam
mattress
overlay
systemat
review
conclud
special
foam
mattress
overlay
special
sheepskin
overlay
reduc
incid
pressur
ulcer
compar
standard
mattress
sinc
limit
prevent
approach
pressur
ulcer
less
costli
one
focus
treat
establish
ulcer
patient
identifi
ed
quickli
possibl
whether
addit
advantag
ulcer
prevent
use
expens
airfl
uidiz
bed
unclear
bed
make
nurs
care
diffi
cult
usual
reserv
treat
patient
establish
extens
ulcer
prefer
seat
cushion
one
distribut
pressur
uniformli
weightbear
bodi
surfac
doughnut
cushion
use
prevent
measur
indwel
condom
cathet
sometim
need
treat
stage
iv
ulcer
use
caution
physic
examin
temperatur
blood
pressur
crackl
note
right
lower
lung
fi
eld
remaind
physic
examin
normal
laboratori
data
reveal
hemoglobin
leukocyt
count
blood
urea
nitrogen
mgdl
creatinin
mgdl
glucos
chest
xray
reveal
right
lower
lobe
infi
ltrate
blood
cultur
sputum
gram
stain
pend
follow
appropri
manag
patient
begin
empir
antibiot
admit
intens
care
unit
b
begin
empir
antibiot
admit
medic
ward
c
discharg
oral
antibiot
therapi
administ
singl
dose
empir
antibiot
discharg
oral
antibiot
therapi
correct
level
care
patient
includ
admit
medic
ward
intraven
antibiot
score
estim
mortal
risk
base
upon
follow
indic
confus
blood
urea
nitrogen
level
respiratori
rate
per
minut
systol
blood
pressur
diastol
pressur
age
year
older
one
point
score
posit
indic
patient
score
low
mortal
risk
consid
outpati
treatment
score
hospit
patient
score
consid
admiss
intens
care
unit
patient
score
predict
mortal
risk
hospit
recommend
patient
score
higher
compar
complic
pneumonia
sever
index
psi
predict
mortal
pneumonia
shown
psi
better
predictor
shortterm
mortal
hospit
initi
perform
improv
plan
decreas
rate
catheterassoci
urinari
tract
infect
follow
patient
current
meet
indic
indwel
urinari
cathet
usag
male
prostat
cancer
urin
day
cc
urin
present
bladder
scan
b
femal
unabl
use
bedsid
commod
request
foley
cathet
hospit
c
man
urinari
incontin
stage
sacral
ulcer
e
c
f
b
c
answer
e
accept
indic
indwel
urinari
cathet
includ
follow
clinic
signifi
cant
urinari
retent
temporari
relief
comfort
termin
ill
patient
accur
urin
output
monitor
critic
ill
patient
prolong
surgic
procedur
gener
spinal
anesthesia
aid
heal
stage
sacral
decubitu
ulcer
fail
treatment
worsen
due
urinari
incontin
patient
prefer
urinari
incontin
monitor
urinari
output
stabl
patient
indic
indwel
urinari
cathet
avoid
physic
examin
day
admiss
temperatur
normal
blood
pressur
mmhg
puls
rate
beatsmin
respiratori
rate
breathsmin
cardiopulmonari
examin
normal
letharg
famili
report
depress
dysarthria
left
arm
leg
weak
upper
airway
congest
note
bedsid
dysphagia
screen
unabl
safe
swallow
water
mild
cough
follow
appropri
next
step
manag
earli
rehabilit
b
amoxicillin
c
modafi
nil
stent
intern
carotid
e
paroxetin
answer
rehabilit
initi
patient
soon
medic
stabl
acut
ischem
stroke
identifi
ed
caus
result
signifi
cant
motor
dysfunct
earli
rehabilit
multipl
benefi
cial
effect
stroke
recoveri
physic
therapi
may
prevent
risk
deep
venou
thrombosi
atelectasi
contractur
skin
breakdown
evalu
speech
swallow
therapist
abil
swallow
liquid
safe
step
improv
stroke
recoveri
includ
screen
treat
poststrok
depress
minim
occurr
poststrok
medic
complic
pneumonia
urinari
tract
infect
prophylact
antibiot
stroke
patient
risk
aspir
shown
effect
reduc
incid
pneumonia
central
nervou
system
stimul
modafi
nil
unlik
help
patient
earli
recoveri
gener
pharmacolog
agent
includ
amphetamin
antidepress
indic
acut
phase
yet
shown
improv
stroke
recoveri
stent
intern
carotid
arteri
indic
patient
experienc
recurr
symptom
indic
stent
set
carotid
arteri
dissect
known
despit
overal
declin
thrombot
event
due
increas
use
prevent
prophylaxi
pulmonari
embol
result
deep
vein
thrombosi
thromboembol
remain
common
prevent
caus
hospit
death
debat
event
defi
ned
prevent
death
suggest
overestim
number
pulmonari
embol
case
classifi
ed
prevent
hospit
death
answer
e
patient
acut
pancreat
recov
without
complic
overal
mortal
rate
ill
sever
tool
develop
predict
outcom
pancreat
bedsid
index
sever
acut
pancreat
bisap
score
may
replac
ranson
criteria
apach
ii
sever
score
modal
assess
sever
pancreat
valid
studi
accur
measur
sever
pancreat
easier
calcul
better
predict
outcom
bedsid
index
sever
acut
pancreat
score
incorpor
fi
variabl
determin
sever
bun
greater
mgdl
impair
mental
statu
presenc
sir
age
year
pleural
effus
radiographi
presenc
three
factor
associ
increas
risk
inhospit
mortal
answer
care
must
taken
interpret
studi
look
qualiti
endpoint
among
differ
hospit
servic
studi
often
show
confl
ict
result
specialti
servic
provid
better
qualiti
costeffi
cient
care
may
depend
resourc
alloc
patient
select
conduct
studi
research
conduct
minneapoli
heart
institut
track
readmiss
rate
patient
admit
heart
failur
readmiss
rate
cardiologist
vs
patient
discharg
hospitalist
even
though
cardiologist
treat
patient
sever
diseas
research
found
cardiologist
better
job
hospitalist
call
patient
discharg
make
sure
patient
outpati
appoint
ensur
followup
nurs
practition
length
stay
similar
specialti
cardiologist
util
resourc
deliv
expens
care
next
step
repeat
urin
cultur
confi
rm
erad
organ
b
renal
ultrasound
c
cystoscopi
repeat
urinalysi
week
answer
american
urolog
associ
recommend
urin
test
imag
comput
tomographi
scan
intraven
pyelogram
plu
renal
ultrasound
cystoscopi
patient
age
year
older
red
blood
cell
per
high
power
fi
eld
two
three
properli
collect
urinalys
patient
classic
uti
may
account
rbc
seen
would
reason
repeat
urinalysi
week
also
smoker
therefor
risk
uroepitheli
malign
followup
urolog
well
may
appropri
case
use
diuret
treatment
acut
kidney
injuri
aki
critic
ill
patient
like
result
follow
reduct
mortal
b
improv
renal
recoveri
c
shorten
durat
acut
kidney
ill
reduct
need
renal
replac
therapi
e
increas
urin
output
sodium
excret
answer
e
although
tempt
use
diuret
anur
oliguria
renal
failur
data
support
use
diuret
may
increas
urin
output
sodium
excret
ineffect
even
detriment
prevent
treatment
aki
neither
shorten
durat
aki
reduc
need
renal
replac
therapi
answer
varieti
drug
caus
druginduc
hemolysi
drug
list
piperacillintazobactam
highest
risk
follow
metformin
experi
refer
laboratori
cefotetan
ceftriaxon
piperacillin
respons
case
diha
cefotetan
account
major
case
man
admit
medic
intens
care
unit
sepsi
associ
pneumococc
pneumonia
requir
mechan
ventil
well
vasopressor
icu
third
hospit
day
transfer
servic
urin
output
drop
creatinin
increas
mgdl
acut
tubular
injuri
suspect
next
day
creatinin
continu
rise
slowli
mgdl
stabil
potassium
remain
meql
patient
oligur
urin
output
continu
increas
recov
well
pneumonia
eat
well
particip
physic
therapi
follow
would
improv
renal
recoveri
furosemid
b
bosentan
c
lowdos
dopamin
continu
renal
replac
therapi
crrt
e
hemodialysi
f
none
answer
f
clear
consensu
often
perform
hemodialysi
set
acut
kidney
injuri
aki
studi
suggest
earli
initi
may
benefi
cial
one
prospect
trial
aggress
dialysi
improv
recoveri
surviv
rate
mani
author
suggest
hemodialysi
may
delay
recoveri
patient
aki
addit
seem
differ
outcom
use
intermitt
hemodialysi
continu
renal
replac
therapi
crrt
sever
aki
hemodialysi
still
consid
standard
therapi
dialysi
start
abil
measur
recoveri
limit
patient
urin
output
increas
creatinin
stabil
sepsi
resolv
point
toward
recoveri
renal
function
indic
dialysi
aki
includ
hyperkalemia
refractori
medic
therapi
correct
sever
acidbas
disturb
refractori
medic
therapi
sever
azotemia
bun
clinic
studi
fail
establish
benefici
role
lowdos
dopamin
infus
compar
middl
age
younger
adult
elderli
patient
increas
readmiss
rate
follow
condit
heart
failur
b
pneumonia
c
acut
mi
answer
correct
e
none
man
sever
coronari
arteri
diseas
admit
icu
respiratori
failur
shock
sourc
shock
uncertain
procalcitonin
level
order
follow
true
concern
procalcitonin
level
elev
procalcitonin
level
mitig
myocardi
infarct
b
procalcitoninguid
strategi
decreas
patient
mortal
risk
c
low
procalcitonin
level
exclud
bacteri
infect
high
procalcitonin
level
specifi
c
bacteri
infect
e
low
procalcitonin
level
make
septic
shock
less
like
answer
e
low
procalcitonin
level
primarili
predict
decreas
incid
septic
shock
procalcitonin
pct
biomark
exhibit
greater
specifi
citi
marker
identifi
patient
sepsi
aid
diagnosi
bacteri
infect
level
procalcitonin
increas
sepsi
proport
sever
infect
pct
level
highest
patient
bacteri
infect
level
also
high
patient
viral
fungal
infect
bacteremia
usual
associ
high
procalcitonin
level
low
level
exclud
diagnosi
procalcitonin
level
report
increas
myocardi
infarct
pancreat
exact
clinic
use
yet
determin
use
studi
result
decreas
mortal
yet
procalcitonin
level
predict
declin
success
sourc
control
may
best
use
marker
one
use
may
deescal
antibiot
procalcitonin
prohormon
calcitonin
healthi
hospic
nurs
care
patient
termin
ill
aid
accident
stuck
needl
use
draw
blood
needl
prick
skin
drew
bare
notic
amount
blood
nurs
upset
call
immedi
regard
risk
exposur
hiv
viru
postexposur
treatment
appropri
action
reassur
b
treat
test
posit
c
start
threedrug
antiretrovir
therapi
continu
day
start
antiretrovir
therapi
zidovudin
continu
month
answer
c
nurs
immedi
treat
threedrug
antivir
therapi
nurs
risk
infect
base
sourc
type
exposur
hiv
circul
viral
burden
highest
initi
stage
infect
pretermin
advanc
stage
case
hollow
needl
use
draw
blood
associ
higher
viral
inoculum
solid
needl
expand
regimen
three
drug
day
advoc
center
diseas
control
prevent
hiv
postexposur
prophylaxi
initi
ideal
within
h
injuri
hospitalist
nurs
staff
awar
current
protocol
activ
time
manner
prior
bleed
abstin
alcohol
year
stabil
given
unit
fresh
frozen
plasma
unit
pack
red
blood
cell
inr
admiss
octreotid
infus
start
esophagogastroduodenoscopi
show
three
column
grade
esophag
varic
activ
bleed
sourc
found
hemostasi
achiev
band
ligat
sever
esophag
varic
vital
sign
remain
stabl
post
procedur
transfer
back
fl
oor
follow
done
increas
patient
surviv
pack
red
blood
cell
achiev
target
hematocrit
greater
b
continu
octreotid
infus
day
total
c
intraven
ceftriaxon
daili
day
fresh
frozen
plasma
correct
coagulopathi
inr
less
e
intraven
pantoprazol
twice
daili
day
answer
c
intraven
antibiot
ceftriaxon
ciprofl
oxacin
proven
surviv
benefi
patient
cirrhosi
portal
hypertens
bleed
recommend
administ
earli
cours
continu
day
target
hematocrit
risk
increas
portal
pressur
excess
fresh
frozen
plasma
administr
increas
portal
pressur
risk
transfusionassoci
lung
injuri
clear
surviv
benefi
intraven
pantoprazol
set
varic
bleed
even
band
ligat
octreotid
infus
lower
portal
pressur
usual
emerg
recommend
h
patient
chronic
liver
diseas
hemoglobin
threshold
transfus
red
cell
patient
acut
gastrointestin
bleed
associ
signifi
cantli
improv
outcom
gdl
aggress
b
gdl
liber
strategi
c
gdl
restrict
strategi
threshold
answer
c
restrict
strategi
gdl
improv
probabl
surviv
decreas
bleed
recent
studi
within
fi
rst
day
portalpressur
gradient
increas
signifi
cantli
patient
assign
liber
strategi
assign
restrict
strategi
signifi
cantli
higher
subgroup
patient
cirrhosi
childpugh
class
b
c
diseas
possibl
due
increas
portal
pressur
seen
group
mortal
day
signifi
cantli
lower
group
fewer
transfus
addit
patient
lower
transfus
goal
less
like
reble
discharg
hospit
sooner
patient
hypovolem
shock
cardiovascular
diseas
might
still
benefi
higher
transfus
threshold
american
heart
associ
guidelin
reduc
heart
failur
readmiss
includ
follow
except
identifi
patient
suitabl
guidelinedirect
medic
therapi
b
develop
patient
educ
program
emphas
discharg
care
c
develop
home
electron
monitor
system
util
nurs
staff
diseas
manag
e
conduct
patient
followup
day
week
postdischarg
answer
c
intervent
rel
inexpens
avail
hospit
chosen
includ
four
simpl
lowtech
intervent
identifi
heart
failur
patient
appropri
goaldirect
therapi
develop
transit
care
discharg
plan
emphas
patient
educ
increas
treatment
complianc
manag
comorbid
condit
effect
tackl
psychosoci
barrier
care
readmiss
continu
signifi
cant
reform
topic
seen
maker
overal
system
qualiti
object
measur
investig
silent
pulmonari
embol
patient
deep
vein
thrombosi
may
benefi
suffer
pulmonari
embol
increas
risk
embol
recurr
especi
fi
rst
day
also
concern
pe
found
followup
may
incorrectli
diagnos
new
pe
may
lead
fals
assumpt
anticoagul
fail
patient
despit
factor
guidelin
current
recommend
pe
screen
patient
dvt
male
admit
diagnosi
copd
exacerb
day
ago
develop
acut
respiratori
distress
elev
carbon
dioxid
patient
intub
place
invas
mechan
ventil
improv
treatment
includ
methylprednisolon
albuterol
levofl
oxacin
toler
wean
trial
well
decis
made
extub
well
remain
hypercapn
transfer
fl
oor
physic
examin
alert
awak
blood
pressur
mmhg
puls
rate
beat
per
minut
pulmonari
examin
reveal
normal
breath
sound
mild
wheez
follow
intervent
decreas
patient
risk
reintub
incent
spirometri
everi
h
b
noninvas
posit
pressur
ventil
c
nebul
nacetylcystein
inhal
heliumoxygen
mixtur
answer
b
noninvas
posit
pressur
ventil
nppv
h
extub
may
reduc
need
reintub
method
wean
critic
ill
adult
invas
ventil
nppv
signifi
cantli
associ
reduc
mortal
ventilatorassoci
pneumonia
mani
circumst
nppv
toler
use
incent
spirometri
reduc
risk
postop
pulmonari
complic
limit
role
routin
manag
nonsurg
patient
follow
extub
nacetylcystein
mucolyt
agent
particular
patient
secret
seem
confound
factor
addit
nacetylcystein
may
trigger
bronchospasm
would
recommend
man
coronari
arteri
diseas
heart
failur
admit
hospit
worsen
short
breath
outpati
medic
ace
inhibitor
aspirin
betaadrenerg
block
agent
underli
pulmonari
diseas
physic
exam
temperatur
puls
rate
beat
per
minut
respiratori
rate
breath
per
minut
blood
pressur
mmhg
arteri
mmhg
mmhg
ph
oxygen
nonbreath
mask
radiograph
chest
reveal
diffus
opac
consist
pulmonari
edema
start
continu
posit
airway
pressur
ventil
cpap
follow
decreas
use
cpap
acut
cardiogen
edema
stroke
b
intraaort
balloon
pump
support
c
need
revascular
surgeri
new
myocardi
infarct
e
wors
outcom
bipap
f
death
answer
f
respiratori
compromis
may
develop
patient
cardiogen
pulmonari
edema
patient
may
requir
respiratori
support
continu
posit
airway
pressur
cpap
effect
acut
cardiogen
pulmonari
edema
metaanalysi
demonstr
cpap
reduc
risk
intub
death
protect
new
myocardi
infarct
need
revascular
stroke
use
balloon
pump
posit
airway
pressur
well
use
acut
exacerb
chronic
obstruct
pulmonari
diseas
also
use
effect
cardiogen
edema
well
current
data
insuffi
cient
compar
effi
caci
safeti
bipap
cpap
answer
b
hospitalist
fi
eld
rel
new
littl
formal
research
malpractic
claim
hospitalist
compar
specialist
internist
liabil
risk
overal
malpractic
claim
hospitalist
appear
low
although
malpractic
claim
hospitalist
low
compar
specialti
area
hospitalist
seen
increas
claim
probabl
occur
hospitalist
continu
expand
scope
practic
particularli
area
comanag
neurosurg
patient
studi
close
claim
doctor
compani
found
common
alleg
involv
hospitalist
improp
manag
treatment
cours
delay
treatment
failur
treat
diagnosisrel
error
improp
medic
manag
failur
monitor
physiolog
statu
patient
answer
fifti
percent
case
acut
mesenter
ischemia
ami
caus
embol
emboli
usual
origin
left
atrium
ventricl
often
sourc
found
atrial
fi
brillat
recent
myocardi
infarct
emboli
lodg
distal
major
branch
point
abdomin
distent
gastrointestin
bleed
primari
present
symptom
mani
patient
pain
may
abrupt
sever
unrespons
opioid
bowel
becom
gangren
rectal
bleed
sign
sepsi
develop
rapidli
recogn
treat
ami
poor
outcom
consid
patient
abdomin
pain
disproportion
physic
fi
nding
presenc
risk
factor
especi
age
older
year
high
mortal
diffi
culti
diagnosi
mesenter
ischemia
pose
substanti
legal
risk
legal
risk
reduc
earli
surgic
consult
prompt
imag
sach
sm
morton
jh
schwartz
si
acut
mesenter
ischemia
surgeri
answer
due
frequenc
varieti
present
pulmonari
embol
remain
common
miss
diagnosi
found
autopsi
true
past
current
studi
studi
patient
die
unexpectedli
pulmonari
embol
hospit
outsid
reveal
patient
complain
varieti
vagu
symptom
often
week
forti
percent
patient
seen
physician
week
prior
death
highrisk
patient
diagnosi
pulmonari
embol
sought
activ
patient
respiratori
symptom
unexplain
altern
diagnosi
surg
male
sever
chronic
obstruct
pulmonari
diseas
admit
icu
develop
acut
delirium
postextub
h
gradual
improv
support
care
transfer
medicin
servic
prepar
discharg
skill
nurs
facil
debilit
cognit
abil
seem
near
baselin
prior
episod
live
famili
concern
cognit
declin
would
impact
abil
live
independ
follow
statement
correct
patient
admit
diagnosi
develop
delirium
hospit
neurolog
outcom
b
longterm
cognit
impair
patient
delirium
seen
younger
patient
c
use
antipsychot
hospit
correl
level
cognit
impair
patient
develop
delirium
critic
ill
risk
develop
persist
cognit
impair
year
answer
develop
delirium
predict
cognit
impair
year
critic
ill
case
may
perman
cognit
declin
durat
delirium
independ
predictor
longterm
cognit
impair
note
patient
age
well
develop
delirium
may
predictor
underli
cognit
impair
dementia
fi
rst
day
hospitalist
call
emerg
room
admit
case
abdomin
pain
due
pancreat
ed
physician
start
present
state
patient
alcohol
question
patient
report
histori
alcohol
deni
recent
alcohol
intak
past
sever
year
suspect
still
drink
amylas
lipas
normal
etoh
detect
admit
diagnosi
pancreat
start
iv
fl
uid
pain
control
sever
day
later
resolut
symptom
gastroenterolog
consult
conclud
pancreat
unlik
undergo
egd
diagnos
sever
gastriti
made
follow
type
medic
error
made
anchor
b
heurist
c
cultur
bia
frame
answer
anchor
error
occur
clinician
cling
initi
impress
even
confl
ict
contradictori
data
accumul
tendenc
frame
clinic
problem
around
fi
rst
piec
inform
receiv
often
sens
reward
confi
denc
go
fi
rst
instinct
addit
hierarch
natur
medicin
often
place
greater
emphasi
opinion
certain
staff
case
pancreat
certainli
possibl
data
point
otherwis
tendenc
stick
origin
diagnosi
consid
option
even
face
confl
ict
evid
male
hospit
treatment
osteomyel
left
foot
result
chronic
diabet
ulcer
medic
histori
signifi
cant
type
diabet
mellitu
hypertens
chronic
kidney
diseas
baselin
serum
creatinin
mg
dl
creatinin
chang
admiss
current
follow
renal
servic
patient
initi
broadspectrum
antibiot
subsequ
cultur
grew
klebsiella
discharg
longterm
care
facil
physic
therapi
complet
cours
intraven
antibiot
follow
appropri
rout
access
antibiot
patient
answer
c
everi
attempt
made
continu
use
peripher
intraven
access
patient
patient
chronic
kidney
diseas
eventu
requir
hemodialysi
central
cathet
may
interfer
placement
futur
graft
place
discuss
nephrolog
vascular
servic
femal
admit
hospit
congest
heart
failur
attend
physician
histori
new
york
heart
associ
class
iii
ischem
cardiomyopathi
past
medic
histori
signifi
cant
congest
heart
failur
well
syncop
due
recurr
ventricular
tachycardia
third
day
hospit
patient
found
nonrespons
cardiac
arrest
team
call
arriv
time
cardiac
arrest
team
patient
pulseless
chest
compress
begun
famili
room
famili
request
stay
present
resuscit
effort
follow
true
concern
outcom
famili
member
present
cardiac
resuscit
lower
rate
posttraumat
stress
disord
seen
famili
member
b
longer
durat
cardiac
resuscit
c
increas
rate
stress
note
team
member
improv
outcom
e
wors
outcom
answer
sever
studi
look
presenc
famili
member
cardiac
resuscit
shown
posit
outcom
mani
paramet
offer
elect
remain
present
signifi
cant
fi
nding
demonstr
lower
risk
posttraumat
stress
disord
famili
member
day
event
clinic
outcom
well
durat
resuscit
found
equal
suggest
durat
code
may
actual
shorter
famili
member
present
sever
current
guidelin
suggest
famili
member
offer
opportun
present
cardiac
resuscit
measur
space
allow
hospit
staff
may
feel
uncomfort
arrang
provid
train
prior
establish
protocol
answer
f
clinic
trial
suggest
devic
reduc
pressur
superior
standard
mattress
clear
advantag
one
devic
anoth
goal
maintain
tissu
pressur
less
mmhg
theori
reduct
tissu
pressur
capillari
fi
lling
pressur
allow
adequ
tissu
perfus
individu
thought
risk
develop
pressur
ulcer
place
pressurereduc
devic
sever
trial
compar
differ
devic
dynam
air
mattress
water
fl
otat
system
static
support
overlay
term
incid
sever
pressur
ulcer
occur
use
studi
devic
effect
prevent
pressur
ulcer
femal
present
emerg
room
due
confus
headach
past
h
histori
hypertens
often
uncontrol
treat
hydrochlorothiazid
clonidin
report
famili
blood
pressur
often
systol
physic
exam
patient
note
diaphoret
confus
heart
rate
beat
per
minut
blood
pressur
mmhg
tachycard
edema
note
focal
neurolog
defi
cit
note
laboratori
studi
signifi
cant
creatinin
mgdl
baselin
mgdl
rest
chemistri
within
normal
limit
follow
appropri
blood
pressur
goal
fi
rst
hour
treatment
mmhg
b
mmhg
c
mmhg
mmhg
e
mmhg
answer
b
patient
hypertens
emerg
hypertens
emerg
formerli
call
malign
hypertens
hypertens
acut
impair
one
organ
system
defi
ned
blood
pressur
greater
progress
target
organ
dysfunct
encephalopathi
intracerebr
hemorrhag
myocardi
infarct
acut
left
ventricular
failur
unstabl
angina
dissect
aortic
aneurysm
eclampsia
hypertens
emerg
differ
hypertens
crisi
former
evid
acut
organ
damag
goal
therapi
reduc
blood
pressur
within
fi
rst
hour
within
next
h
reduct
occur
next
h
except
manag
acut
cerebrovascular
accid
excess
reduct
blood
pressur
precipit
coronari
cerebr
renal
ischemia
possibl
infarct
trial
exist
compar
effi
caci
variou
agent
treatment
hypertens
emerg
drug
chosen
base
onset
action
eas
use
predict
convent
answer
lower
gastrointestin
bleed
lgib
frequent
caus
hospit
admiss
factor
hospit
morbid
mortal
common
etiolog
lgib
diverticulosi
hemorrhoid
carcinoma
diverticulosi
domin
etiolog
massiv
lgib
public
diverticular
bleed
occur
without
concomit
diverticul
risk
factor
diverticular
bleed
includ
lack
dietari
fi
ber
constip
advanc
age
use
nonsteroid
antiinfl
ammatori
drug
nsaid
aspirin
patient
present
lgib
sourc
bleed
upper
gastrointestin
gi
tract
follow
scenario
appropri
allow
outpati
treatment
communityacquir
pneumonia
cap
male
cap
confus
b
male
cap
respiratori
rate
c
femal
cap
creatinin
mgdl
femal
cap
low
blood
pressur
confus
e
femal
cap
alter
mental
statu
respiratori
rate
blood
pressur
mmhg
answer
b
case
cap
safe
treat
outpati
guidelin
develop
assist
appropri
level
care
treat
cap
acronym
stand
c
confus
u
uremia
r
respiratori
rate
greater
b
blood
pressur
low
less
mmhg
systol
less
mmhg
diastol
age
year
greater
categori
assign
point
point
total
mean
patient
treat
outpati
point
total
requir
treatment
medic
ward
point
total
requir
icu
admiss
male
cap
respiratori
rate
min
treat
outpati
patient
one
point
age
greater
year
age
curb
score
simpli
serv
guidelin
factor
home
situat
comorbid
access
health
care
must
consid
femal
present
sepsi
due
pneumonia
admit
intens
care
unit
intub
start
broadspectrum
antibiot
histori
vitamin
defi
cienci
prescrib
replac
therapi
note
take
found
mark
vitamin
defi
cienci
true
concern
highdos
vitamin
replac
length
stay
improv
b
sixmonth
mortal
improv
c
function
statu
improv
e
none
answer
e
low
vitamin
statu
link
increas
mortal
morbid
patient
critic
ill
mechan
vitamin
defi
cienci
associ
increas
mortal
patient
sepsi
may
relat
immunolog
effect
unknown
replac
therapi
improv
outcom
critic
ill
patient
vitamin
defi
cienci
benefi
replac
compar
placebo
reduct
length
stay
hospit
mortal
mortal
note
studi
femal
admit
uti
accord
previou
cultur
patient
posit
pansensit
escherichia
coli
ciprofl
oxacin
start
empir
new
cultur
return
decid
dosag
regimen
start
patient
renal
dosag
adjust
equat
util
cdai
consid
standard
assess
diseas
activ
crohn
diseas
valid
index
vari
infl
ammatori
bowel
diseas
questionnair
ibdq
develop
incorpor
subject
element
pertain
qualiti
life
well
bowelrel
symptom
activ
index
intern
medicin
resid
sustain
needlestick
injuri
attempt
insert
central
line
patient
servic
resid
contact
sever
emot
distress
due
possibl
hiv
transmiss
sourc
patient
compet
inform
injuri
refus
provid
consent
human
immunodefi
cienci
viru
hiv
test
year
ago
resid
becam
ill
take
postexposur
prophylaxi
pep
similar
exposur
ask
use
blood
complet
blood
count
alreadi
taken
sourc
patient
reason
test
hiv
follow
true
statement
hiv
test
sourc
patient
permit
state
without
consent
b
hiv
test
sourc
patient
allow
without
consent
state
c
hiv
test
sourc
patient
allow
without
consent
court
order
hiv
test
sourc
patient
without
consent
allow
state
answer
state
law
regul
hiv
sourc
patient
test
practic
unit
state
controversi
hiv
test
case
occup
exposur
refl
ect
variat
state
law
polici
state
law
allow
uncons
hiv
test
sourc
patient
case
occup
exposur
state
requir
uncons
hiv
test
variat
exist
numer
procedur
includ
author
uncons
test
test
document
medic
record
inform
test
result
particular
case
prompt
postexposur
treatment
may
need
import
state
polici
understood
allow
rapid
decisionmak
process
occur
follow
symptom
inconsist
diagnosi
syndrom
gb
histori
bilater
weak
abdomin
thigh
pain
b
bilater
lower
extrem
weak
normal
magnet
reson
imag
head
spine
c
patient
bilater
lower
extrem
weak
paresthesia
markedli
decreas
refl
exe
lower
extrem
patient
present
symmetr
sensori
loss
physic
examin
motor
weak
e
facial
droop
dysarthria
answer
present
classic
symptom
often
present
patient
atyp
present
often
delay
diagnosi
often
diagnos
psycholog
reaction
frequent
sent
home
emerg
depart
return
persist
progress
symptom
hour
day
later
hallmark
ascend
motor
weak
sensori
loss
may
present
motor
weak
predomin
consist
fi
nding
univers
fl
exia
usual
present
syndrom
although
patient
distal
arefl
exia
painrel
symptom
occur
half
urinari
retent
rare
persist
anal
sphincter
muscl
rare
affect
well
classic
cerebrospin
spinal
fi
nding
elev
protein
normal
white
blood
cell
count
present
time
within
fi
rst
week
second
week
patient
elev
csf
protein
level
emg
often
show
typic
pattern
present
may
evolv
time
cranial
nerv
involv
observ
patient
gb
cranial
nerv
iiivii
ixxii
may
affect
mean
time
present
clinic
function
nadir
day
patient
reach
nadir
week
progress
symptom
beyond
week
bring
diagnosi
question
recoveri
usual
begin
week
progress
ceas
mean
time
clinic
recoveri
day
otherwis
seem
function
abl
comprehend
patient
present
far
know
troubl
substanc
abus
past
appropri
action
notifi
hospit
administr
b
advis
colleagu
seek
care
respect
right
privaci
c
inform
colleagu
must
remov
practic
area
immedi
inform
chief
hospit
medicin
answer
c
circumst
hospit
advoc
respons
manag
situat
hand
appropri
treatment
team
secondarili
respons
colleagu
patient
immedi
defi
nitiv
action
requir
set
suspect
acut
intox
physician
healthcar
provid
provid
patient
care
might
reason
expect
provid
care
near
futur
immedi
remov
practic
set
essenti
case
intervent
may
includ
accompani
suspect
physician
establish
health
care
environ
emerg
depart
secur
need
may
involv
trial
trial
chines
trial
compar
lower
blood
pressur
target
less
mmhg
systol
within
h
guidelinerecommend
approach
lower
pressur
less
mmhg
drug
commonli
use
urapidil
popular
drug
china
use
extens
unit
state
qualityoflif
assess
suggest
patient
intens
treatment
group
fewer
problem
signifi
cantli
better
overal
healthrel
qualiti
life
day
standard
treatment
group
subgroup
underw
brain
imag
small
reduct
hematoma
growth
intens
treatment
group
fi
nding
signifi
cant
found
unit
state
b
offi
cial
partnership
world
health
organ
c
forprofi
organ
group
conduct
random
control
trial
answer
b
systemat
review
import
practic
evidencebas
health
care
one
largest
organ
cochran
collabor
cochran
collabor
independ
nonprofi
nongovernment
organ
consist
primarili
volunt
countri
group
conduct
systemat
review
random
control
trial
medic
non
medic
intervent
undertak
prospect
trial
cochran
collabor
split
smaller
divis
compos
center
review
group
method
group
fi
eld
averag
cochran
systemat
review
take
month
protocol
public
critic
time
frame
although
cochran
review
done
much
dilig
review
come
scrutini
overreach
conclus
answer
sever
studi
shown
fragment
care
caus
increas
length
stay
lo
one
studi
publish
journal
hospit
medicin
reveal
increas
fragment
associ
increas
day
pneumonia
increas
day
lo
heart
failur
fragment
defi
ned
percentag
patient
seen
physician
physician
provid
major
care
protocoldriven
admiss
process
make
easi
overlook
fundament
right
patient
autonomi
goal
care
situat
determin
signifi
cant
effort
undertaken
answer
c
obes
increas
risk
fals
low
btype
natriuret
peptid
bnp
level
bnp
especi
help
differenti
dyspnea
result
heart
failur
versu
dyspnea
result
pulmonari
diseas
bnp
good
neg
predict
valu
among
patient
present
emerg
depart
dyspnea
undetermin
caus
bnp
level
less
pgml
accur
exclud
decompens
heart
failur
caus
clinic
use
ambulatori
set
uncertain
among
ambulatori
patient
establish
heart
failur
normal
rang
bnp
period
clinic
stabil
may
high
pgml
factor
heart
failur
affect
bnp
level
includ
kidney
failur
older
age
femal
sex
increas
bnp
level
bnp
level
may
also
elev
mani
caus
ventricular
strain
includ
pulmonari
embol
acut
myocardi
infarct
acut
tachycardia
studi
show
reduc
recurr
pe
increas
risk
dvt
ivc
fi
lter
associ
reduct
mortal
fi
lter
use
ivc
fi
lter
commonli
use
prophylaxi
highrisk
patient
includ
trauma
patient
neurosurg
patient
patient
malign
superobes
patient
undergo
surgeri
whether
use
lead
net
benefi
known
ivc
placement
recommend
anticoagul
resum
soon
possibl
fi
lter
insert
fi
lter
alon
effect
treatment
venou
thromboembol
vte
retriev
fi
lter
may
offer
benefi
without
longterm
complic
ivc
fi
lter
characterist
patient
rate
physician
highest
patient
satisfact
score
lower
mortal
b
decreas
healthcar
expenditur
c
decreas
prescript
drug
use
e
none
answer
e
patient
satisfact
becom
common
metric
hospit
medicin
physician
balanc
provid
qualiti
care
meet
expect
patient
challeng
satisfi
ed
patient
necessarili
healthi
patient
paper
publish
research
univers
california
davi
use
data
nearli
adult
found
satisfi
ed
patient
spent
healthcar
prescript
drug
like
admit
hospit
account
total
healthcar
cost
mortal
also
increas
although
studi
prove
causal
effect
question
relationship
patient
satisfact
qualiti
friedberg
mw
gelb
safran
schneider
ec
satisfi
ed
death
spuriou
result
arch
intern
med
man
admit
histori
cough
dyspnea
hemoptysi
also
fever
night
sweat
weight
loss
last
month
signifi
cant
medic
histori
smoke
use
alcohol
take
drug
marri
employ
account
take
medic
physic
examin
appear
thin
cough
frequent
temperatur
blood
pressur
mmhg
puls
rate
beatsmin
respiratori
rate
pulmonari
examin
show
crackl
right
upper
lung
fi
eld
follow
appropri
infecti
precaut
order
patient
airborn
b
contact
c
droplet
standard
answer
patient
pneumonia
isol
although
patient
appar
risk
factor
mycobacterium
tuberculosi
tb
differenti
patient
cough
greater
week
loss
appetit
unexplain
weight
loss
night
sweat
hoars
fever
fatigu
chest
pain
index
suspicion
substanti
higher
highrisk
group
often
seen
airborn
precaut
recommend
patient
infect
microorgan
avian
infl
uenza
varicella
dissemin
zoster
sever
acut
respiratori
syndrom
smallpox
agent
viral
hemorrhag
fever
airborn
precaut
may
depend
local
regul
includ
place
patient
isol
room
higheffi
cienci
particul
air
fi
ltration
neg
pressur
anyon
enter
room
wear
fi
ttest
higher
dispos
respir
patient
also
wear
one
transport
room
goggl
gown
glove
worn
contact
respiratori
secret
anticip
contact
precaut
indic
patient
known
suspect
infect
transmit
direct
contact
vancomycinresist
enterococci
methicillinresist
staphylococcu
aureu
droplet
precaut
use
protect
microorgan
transmit
respiratori
droplet
larger
droplet
usual
transmit
distanc
less
ft
exampl
pathogen
diseas
requir
institut
droplet
isol
precaut
includ
neisseria
meningitidi
pneumon
plagu
diphtheria
haemophilu
infl
uenza
type
b
bordetella
pertussi
infl
uenza
mump
rubella
parvoviru
droplet
precaut
includ
place
patient
isol
room
wear
face
surgic
mask
room
wear
goggl
gown
glove
standard
precaut
use
patient
femal
mild
dementia
chronic
kidney
diseas
stage
admit
hospit
pyelonephr
acut
chronic
renal
failur
sinc
admiss
day
ago
improv
clinic
laboratori
paramet
improv
decreas
leukocytosi
repeat
neg
blood
cultur
slight
decreas
serum
creatinin
despit
mild
dementia
baselin
patient
recogn
famili
could
express
need
particip
daili
activ
current
medic
ceftriaxon
aspirin
acetaminophen
hospit
day
develop
mild
delirium
wors
night
last
even
repeatedli
tri
climb
bed
today
pull
intraven
line
even
though
nurs
staff
close
observ
physic
examin
temperatur
heart
rate
beat
per
minut
blood
pressur
mmhg
patient
appear
restless
orient
person
speech
mildli
distort
repeat
three
number
follow
recommend
keep
televis
distract
b
initi
bedsid
sitter
c
place
bilater
wrist
restraint
administr
quetiapin
mg
mgdl
e
lorazepam
mg
nightli
answer
b
current
evid
support
role
sitter
part
manag
patient
delirium
although
use
observ
highrisk
psychiatr
patient
use
sitter
commonli
employ
part
costeffect
manag
deliri
patient
choic
option
proven
benefi
ts
limit
factor
util
sitter
obvious
cost
uncertain
circumst
sitter
costeffect
studi
util
sitter
length
stay
durat
delirium
signifi
cantli
reduc
howev
fall
help
identifi
cation
patient
would
benefi
sitter
use
improv
process
sitter
request
assess
tool
patient
attend
assess
tool
paat
creat
addit
use
train
volunt
suggest
method
increas
sitter
use
man
admit
hemorrhag
stroke
deep
venou
thrombosi
prophylaxi
administ
central
nervou
system
bleed
outpati
medic
includ
aspirin
withheld
well
recoveri
good
patient
transfer
acut
rehabilit
h
admiss
physic
examin
patient
rais
affect
arm
leg
bed
sinc
stroke
incap
walk
without
assist
valu
order
intermitt
pneumat
compress
ipc
devic
patient
reduc
risk
deep
venou
thrombosi
b
reduc
mortal
risk
c
increas
risk
fall
increas
risk
lower
leg
ischemia
amput
answer
ipc
devic
prevent
vte
stroke
thromboembol
common
complic
stroke
lethal
consequ
dvt
prophylaxi
riski
clot
leg
stock
stroke
clot
trial
studi
effi
caci
advers
effect
ipc
devic
stroke
popul
day
patient
receiv
ipc
signifi
cant
reduct
dvt
compar
none
protect
effect
persist
month
effect
similar
whether
anticoagul
use
also
benefi
ipc
whether
stroke
hemorrhag
fall
may
increas
devic
limit
movement
differ
group
slight
increas
skin
break
ipc
group
compar
ipc
skin
break
ipc
group
higher
incid
ischemia
limb
amput
woman
admit
pneumonia
readi
discharg
patient
respond
well
therapi
admiss
notic
dishevel
concern
live
arrang
bmi
current
patient
live
alon
report
diffi
culti
daili
live
daughter
hard
contact
friend
report
patient
home
clutter
dirti
nurs
home
offer
patient
insist
goal
return
home
patient
compet
make
decis
follow
may
best
assist
improv
safeti
home
ethic
consult
b
perform
home
visit
c
insist
higher
standard
safeti
home
avoid
negoti
allow
patient
choos
live
arrang
e
avoid
worstcas
scenario
discuss
answer
b
selfneglect
common
geriatr
practic
famili
support
increasingli
absent
hospitalist
increas
pressur
reduc
readmiss
selfneglect
associ
readmiss
review
articl
smith
et
al
suggest
four
practic
approach
manag
selfneglect
patient
discuss
tactic
gener
work
home
visit
care
provid
team
mean
allow
other
support
patient
home
also
introduc
member
home
care
team
reluct
patient
although
selfneglect
patient
often
lack
resourc
ethic
justifi
cation
insist
higher
standard
safeti
ageism
avoid
negoti
gener
use
tri
help
patient
share
goal
uncompromis
approach
avoid
worstcas
scenario
occur
plan
develop
address
situat
smith
ak
lo
b
aronson
l
elder
selfneglecthow
physician
help
n
engl
j
med
true
concern
use
fl
umazenil
treat
benzodiazepin
bzd
overdos
use
patient
increas
risk
seizur
b
best
use
may
isol
iatrogen
benzodiazepin
overdos
c
use
tricycl
antidepress
overdos
consist
revers
benzodiazepineinduc
respiratori
depress
answer
b
flumazenil
competit
bzd
receptor
antagonist
avail
specifi
c
antidot
bzd
benefi
cial
use
acut
bzd
well
establish
flumazenil
consist
revers
central
respiratori
depress
due
bzd
resed
occur
half
patient
follow
close
longterm
bzd
user
fl
umazenil
may
precipit
withdraw
seizur
flumazenil
use
patient
increas
risk
seizur
head
injuri
coingest
bzd
tricycl
antidepress
agent
may
lower
seizur
threshold
ideal
use
fl
umazenil
may
isol
iatrogen
bzd
overdos
bzdnaiv
patient
compar
nonrestrain
patient
follow
patient
risk
increas
use
sedat
b
increas
patient
safeti
c
decreas
day
intens
care
decreas
incid
advers
event
answer
import
recogn
potenti
neg
physic
psycholog
consequ
restraint
use
physic
restraint
often
necessari
protect
staff
patient
continu
use
judici
attack
nurs
sudden
seriou
life
threaten
trend
healthcar
literatur
violenc
nurs
appear
grow
problem
global
physic
restraint
place
shown
requir
higher
dose
benzodiazepin
opioid
antipsychot
medic
patient
prolong
length
stay
intens
care
unit
icu
patient
higher
rate
selfextub
accident
remov
intraven
cathet
urinari
cathet
feed
tube
discharg
elderli
patient
undergon
physic
restraint
higher
level
posttraumat
stress
disord
factor
make
physic
restraint
one
least
prefer
option
follow
addit
inform
true
concern
io
cannula
intraoss
cannul
may
put
patient
greater
risk
cerebr
fat
emboli
bonemarrow
emboli
b
epinephrin
administr
intraoss
inject
accept
c
administr
medic
intraoss
rout
dose
infus
rate
achiev
intraoss
cannula
compar
rate
achiev
peripher
intraven
cathet
e
answer
e
io
administr
emerg
medic
proven
effect
patient
need
resuscit
establish
intraven
iv
access
diffi
cult
medic
antibiot
epinephrin
blood
product
neuromuscularblock
agent
deliv
intraoss
cannula
requir
dose
adjust
infus
rate
similar
achiev
peripher
intraven
cathet
io
techniqu
fewer
seriou
complic
central
line
may
perform
much
faster
central
peripher
line
vascular
access
diffi
cult
patient
righttoleft
shunt
higher
risk
fat
emboli
bonemarrow
compon
migrat
cerebr
circul
intraoss
cannul
avoid
patient
possibl
investig
genet
infl
uenc
warfarin
dose
requir
three
singlenucleotid
polymorph
snp
found
play
key
role
determin
effect
warfarin
therapi
coagul
studi
shown
achiev
target
inr
occur
rapidli
patient
undergon
genet
test
whether
clinic
signifi
cant
costeffect
uncertain
caraco
blotnick
muszkat
genotypeguid
warfarin
prescrib
enhanc
effi
caci
safeti
anticoagul
prospect
random
control
studi
clin
pharmacol
ther
urgent
contact
resid
exposur
blood
hivposit
patient
place
central
line
glove
rip
sutur
needl
remov
glove
notic
blood
hand
small
scratch
mark
sure
scratch
came
follow
best
postexposur
manag
strategi
resid
tenofovir
emtricitabin
b
tenofovir
emtricitabin
raltegravir
c
tenofovir
emtricitabin
nevirapin
postexposur
prophylaxi
e
immedi
pregnanc
test
prescript
answer
b
us
public
health
servic
recommend
three
drug
use
postexposur
prophylaxi
regimen
regardless
exposur
type
previou
guidelin
offer
two
drug
regimen
exposur
consid
associ
lower
level
transmiss
threedrug
combin
tenofovir
emtricitabin
raltegravir
current
recommend
given
soon
possibl
well
toler
rel
safeti
pregnanc
impact
advanc
resid
train
cover
patient
icu
follow
day
higher
mortal
differ
intervent
b
differ
mortal
intervent
c
higher
patient
mortal
fewer
intervent
lower
patient
mortal
intervent
answer
transfer
care
necessarili
increas
complic
interestingli
one
studi
compar
patient
outcom
critic
care
fellow
assign
cover
patient
overnight
icu
mortal
actual
decreas
intervent
increas
effect
could
possibl
explain
impact
new
review
exist
data
increas
dilig
may
occur
deal
new
patient
propofol
compar
benzodiazepin
sedat
icu
propofol
benzodiazepin
usag
similar
icu
outcom
b
benzodiazepin
usag
better
outcom
c
propofol
usag
better
outcom
answer
c
propofol
oppos
benzodiazepin
usag
appear
associ
better
outcom
icu
benzodiazepin
shown
induc
delirium
oversed
diffi
cult
titrat
believ
inappropri
dose
benzodiazepin
unavoid
given
unpredict
pharmacokinet
benzodiazepin
may
lead
prolong
icu
stay
increas
mortal
recent
larg
studi
patient
examin
associ
sed
use
icu
outcom
propofol
use
associ
reduct
clinic
import
outcom
includ
icu
mortal
hospit
mortal
icu
length
stay
ventil
remov
sedat
day
propofol
use
expens
without
complic
studi
may
need
establish
reduct
complic
offset
expens
follow
lowest
acut
toxic
ingest
requir
acetylcystein
adult
patient
g
b
g
c
g
g
e
g
answer
singl
dose
g
acetaminophen
enough
warrant
acetylcystein
administr
case
g
ingest
nacetylcystein
therapi
initi
patient
present
less
h
acetaminophen
overdos
signifi
cantli
reduc
risk
hepatotox
acetylcystein
use
although
acetylcystein
effect
given
within
h
ingest
still
benefi
cial
effect
given
late
h
ingest
mortal
rate
acetaminophen
overdos
increas
day
ingest
reach
maximum
day
four
gradual
decreas
acetylcystein
usual
well
toler
consid
total
amount
ingest
uncertain
common
advers
reaction
acetylcystein
treatment
anaphylactoid
reaction
manifest
rash
wheez
mild
hypotens
woman
advanc
dementia
hospit
pneumonia
famili
activ
discuss
goal
care
fi
nal
decis
made
howev
patient
respiratori
failur
worsen
even
patient
intub
given
ventil
support
famili
decid
comfort
care
howev
request
patient
remain
hospit
best
medic
care
believ
patient
best
care
remain
icu
follow
choic
would
like
promot
wellb
patient
famili
allow
patient
die
ventilatori
support
icu
without
escal
heroic
measur
b
allow
patient
die
ventilatori
support
icu
c
extub
allow
patient
die
icu
transfer
patient
icu
spironolacton
black
box
warn
patient
famili
histori
breast
cancer
b
famili
histori
thyroid
cancer
c
famili
histori
bladder
cancer
person
histori
colon
cancer
e
person
histori
rectal
cancer
answer
strongest
warn
us
feder
drug
administr
fda
requir
box
warn
signifi
es
medic
studi
indic
drug
carri
signifi
cant
risk
seriou
even
life
threaten
black
box
warn
signifi
cant
effect
drug
use
spironolacton
antiandrogen
potassiumspar
diuret
use
women
adult
acn
recalcitr
treatment
although
fi
rst
line
help
block
androgen
caus
acn
jawlin
spironolacton
black
box
warn
patient
person
histori
breast
cancer
famili
histori
breast
cancer
follow
statement
regard
diagnosi
communityacquir
pneumonia
true
direct
therapi
specifi
c
suspect
caus
organ
effect
empir
therapi
hospit
patient
b
ten
percent
patient
hospit
communityacquir
pneumonia
posit
blood
cultur
c
patient
bacteremia
caus
streptococcu
pneumonia
sputum
cultur
posit
case
polymeras
chain
reaction
test
wide
avail
util
diagnosi
patient
hospit
communityacquir
pneumonia
e
case
pneumonia
specifi
c
infecti
agent
identifi
ed
answer
b
challeng
fi
nd
specifi
c
etiolog
communityacquir
pneumonia
overal
caus
found
approxim
case
gener
yield
sputum
cultur
even
case
fulmin
bacterem
pneumococc
pneumonia
yield
sputum
greater
yield
blood
cultur
also
low
empir
broadspectrum
therapi
remain
standard
therapi
expand
polymeras
chain
reaction
assay
show
promis
mean
target
specifi
c
bacteri
etiolog
avail
cost
test
continu
declin
expect
widespread
use
one
follow
factor
suggest
nonpurul
parapneumon
effus
drain
chest
tube
presenc
pneumococc
pneumonia
b
pleural
fl
uid
ph
c
temperatur
pleural
fl
uid
nucleat
cell
count
answer
b
pleural
effus
common
fi
nding
patient
pneumonia
patient
bacteri
pneumonia
develop
parapneumon
effus
sever
studi
document
nonpurul
parapneumon
effus
low
pleural
ph
less
highest
predict
valu
need
pleural
space
drainag
although
organ
caus
pneumonia
associ
pleural
effus
anaerob
organ
streptococcu
pyogen
staphylococcu
aureu
gramneg
bacilli
tend
higher
frequenc
base
number
case
answer
nhap
close
resembl
communityacquir
pneumonia
cap
nosocomi
pneumonia
usual
pathogen
common
streptococcu
pneumonia
still
common
sever
case
nhap
requir
mechan
ventil
rate
infect
staphylococcu
aureu
enter
gramneg
organ
appear
exceed
pneumonia
nurs
pick
urin
sampl
patient
infect
hiv
leav
room
slip
fell
spill
urin
hand
cloth
thorough
wash
hand
soap
water
chang
cloth
ask
advic
understand
time
import
factor
hiv
prophylaxi
exposur
cut
abras
dermat
sourc
patient
hiv
posit
appropri
manag
healthcar
worker
efavirenz
lamivudin
b
efavirenz
lamivudin
zidovudin
c
kaletra
lamivudin
zidovudin
abacavir
lamivudin
zidovudin
e
observ
answer
e
treatment
antiretrovir
therapi
reserv
highrisk
exposur
needlestick
exposur
bloodi
fl
uid
necessari
case
absenc
blood
saliva
sputum
sweat
tear
fece
nasal
secret
urin
vomitu
carri
low
risk
transmiss
hcv
hiv
man
admit
dysarthria
right
lower
extrem
weak
min
durat
histori
diabet
hypercholesterolemia
hypertens
take
aspirin
hydrochlorothiazid
metformin
simvastatin
daili
ct
head
without
contrast
show
acut
abnorm
tpa
administ
radiolog
intervent
lab
subsequ
ct
scan
day
later
head
demonstr
ischem
stroke
involv
right
pariet
area
echocardiographi
heart
normal
intervent
done
reduc
recurr
stroke
add
clopidogrel
discharg
b
aspirin
warfarin
discharg
c
discontinu
aspirin
start
warfarin
add
dipyridamol
discharg
e
noth
els
optim
treatment
answer
start
clopidogrel
alon
ad
dipyridamol
aspirin
reason
option
guidelin
seventh
american
colleg
chest
physician
accp
confer
antithrombot
thrombolyt
therapi
suggest
combin
extendedreleas
dipyridamol
aspirin
effi
caciou
clopidogrel
patient
alreadi
aspirin
addit
dipyridamol
shown
reduc
risk
stroke
recurr
esprit
profess
trial
addit
clopidogrel
aspirin
increas
risk
cerebr
gi
bleed
substanti
increas
benefi
anticoagul
use
reduc
stroke
recurr
admit
epigastr
pain
esophagogastroduodenoscopi
egd
perform
reveal
mild
gastric
mucos
erythema
addit
abnorm
start
metoclopramid
presum
diabet
gastroparesi
follow
true
regard
metoclopramid
risk
tardiv
dyskinesia
b
longterm
effi
caci
proven
c
improv
symptom
tachygastria
bradygastria
improv
surviv
gastoparet
e
patient
shortest
cours
minim
dose
requir
everi
effort
made
avoid
chronic
use
metoclopramid
answer
e
metoclopramid
approv
shortterm
use
diabet
gastroparesi
one
option
avail
five
control
trial
evalu
effi
caci
metoclopramid
treatment
diabet
gastroparesi
benefi
ts
limit
metoclopramid
demonstr
effect
shortterm
treatment
gastroparesi
sever
week
longterm
effi
caci
proven
one
studi
consist
benefi
observ
use
metoclopramid
month
surviv
diabet
gastroparesi
impact
metoclopramid
use
symptom
bradygastria
improv
diabet
may
also
tachygastr
symptom
would
worsen
improv
metoclopramid
nation
guidelin
estim
risk
develop
tardiv
dyskinesia
td
metoclopramid
chronic
use
metoclopramid
appear
increas
risk
develop
td
prior
initi
treatment
metoclopramid
may
reason
obtain
inform
consent
physician
patient
famili
member
also
document
medic
chart
medicoleg
reason
follow
medic
inpati
profi
le
polyethylen
glycol
b
loperamid
c
b
cholestyramin
answer
c
polyethylen
glycol
osmot
agent
would
increas
bowel
movement
loperamid
act
opioid
intestin
muscl
receptor
inhibit
peristalsi
prolong
transit
time
gi
tract
neither
would
appropri
acut
clostridium
diffi
cile
infect
loperamid
would
potenti
inhibit
excret
toxin
lead
toxic
megacolon
hand
polyethylen
glycol
would
caus
cramp
discomfort
patient
alreadi
experienc
frequenc
bowel
movement
cholestyramin
shown
modest
activ
reduc
stool
frequenc
recommend
use
patient
sever
case
c
diffi
cile
coliti
cholestyramin
bind
vancomycin
must
dose
separ
use
combin
antibiot
approxim
percent
empir
antimicrobi
regimen
remain
unchang
day
hospit
b
c
e
answer
c
broadspectrum
empir
therapi
common
mani
case
protocol
driven
benefi
cial
mani
instanc
certainli
mani
antibiot
guidelin
improv
mortal
howev
often
reluct
deescal
regimen
work
even
clinic
sign
infect
longer
present
deescal
antibiot
indic
associ
lower
mortal
h
suggest
review
microbiolog
data
patient
improv
deescal
broadspectrum
antibiot
narrow
spectrum
procalcitonin
level
also
util
guid
therapi
mani
healthcar
system
develop
antibiot
stewardship
program
address
issu
